Green tea (Camellia sinensis) is the most consumed beverage in the world after water, and among the most intensively studied. Epidemiological data from Japan and China has long associated high green tea consumption with lower rates of cardiovascular disease and certain cancers. Laboratory studies confirm extraordinary antioxidant activity. But translating population-level associations into individual clinical benefit is, as always, complicated.
While Ireland remains primarily a black tea nation — the Irish consume more tea per head than almost any other country — green tea has grown substantially in popularity, driven by health interest and the rise of Japanese cuisine. Green tea is now widely available in Irish supermarkets, health shops, and cafés. High-quality loose leaf green teas (Japanese sencha, matcha, gyokuro; Chinese longjing, gunpowder) are increasingly accessible.
The distinctive health profile of green tea (compared to black tea) comes from its high content of catechins — a class of flavonoid polyphenols preserved because green tea leaves are steamed or pan-fired rather than oxidised/fermented. The main catechins in green tea are:
Matcha (stone-ground whole leaf green tea powder) provides approximately 3–10× more catechins than a steeped leaf tea because you are consuming the entire leaf rather than an infusion.
The epidemiological evidence for green tea and cardiovascular disease is among the most consistent in nutritional epidemiology. A 2006 prospective cohort study by Kuriyama et al. in JAMA (n=40,530 Japanese adults) found those drinking five or more cups of green tea per day had a 26% lower cardiovascular disease mortality rate and a 15% lower all-cause mortality rate compared to those drinking less than one cup per day, after adjustment for confounders.
RCT evidence shows green tea catechins modestly reduce LDL cholesterol and total cholesterol. A meta-analysis by Zheng et al. (2011, PLoS ONE) of 14 RCTs found green tea reduced total cholesterol by approximately 0.15 mmol/L and LDL by 0.13 mmol/L versus control. A Cochrane review (Hartley et al. 2013) of green tea for CVD prevention found modest benefits for cholesterol and blood pressure but noted insufficient evidence to recommend as a clinical intervention for CVD prevention specifically.
Green tea catechins, combined with their caffeine content, have a modest thermogenic effect. A 2009 meta-analysis by Hursel et al. (International Journal of Obesity) of 11 RCTs found green tea catechin-caffeine combinations promoted greater weight loss than caffeine alone, suggesting the catechins contribute independently. However, the absolute effect sizes are modest — approximately 1–3 kg of additional weight loss over 12 weeks in most trials. This is a real but minor effect that is easily overwhelmed by dietary habits.
EGCG has demonstrated potent anti-cancer activity in laboratory settings, targeting multiple pathways including PI3K/AKT signalling, cell cycle arrest, and apoptosis induction in cancer cell lines. Population studies from Japan suggest associations between high green tea consumption and lower rates of some cancers, particularly gastric, oesophageal, and breast cancer. However, the jump from lab evidence and observational epidemiology to "green tea prevents cancer" is not supported by RCT evidence. Green tea should not be used as a cancer preventive in place of standard screening and medical care.
| Claim | Evidence Level | Source |
|---|---|---|
| Green tea reduces cardiovascular mortality | Moderate (epidemiological) | Kuriyama 2006 JAMA; multiple cohort studies |
| Green tea catechins reduce LDL and total cholesterol | Moderate | Multiple RCTs; Zheng 2011 meta-analysis |
| Green tea + caffeine aids modest weight reduction | Moderate | Hursel 2009 meta-analysis (11 RCTs) |
| Green tea prevents cancer in humans | Limited | Epidemiological association; no RCT evidence for prevention |
| EGCG is a potent antioxidant | Strong (lab) | Multiple in vitro studies |
High-dose green tea extract supplements (often providing 400–800 mg EGCG per capsule) have been associated with liver toxicity in case reports, particularly when taken on an empty stomach. Regulatory bodies including the European Food Safety Authority (EFSA) have issued cautionary guidance on high-dose green tea extract supplements, noting that intakes above 800 mg EGCG/day carry potential hepatotoxicity risk. Drinking green tea in beverage form — typically 100–200 mg EGCG per cup — is of negligible hepatotoxicity risk and is the form associated with the positive epidemiological evidence.
Caffeine: Green tea contains 25–50 mg of caffeine per cup (compared to 70–140 mg in a typical espresso). People sensitive to caffeine, pregnant women, and those with anxiety or cardiac arrhythmias should be mindful of green tea caffeine. Matcha contains higher caffeine than steeped leaf tea.
Iron absorption: Green tea catechins significantly inhibit non-haem iron (plant-based iron) absorption when consumed with meals. People with iron deficiency anaemia should drink green tea between meals rather than with food to minimise this interaction.
Anticoagulants: Green tea has mild antiplatelet and pro-coagulant effects (Vitamin K content in whole leaves like matcha is relevant); discuss regular high-quantity matcha consumption with your GP if on warfarin, as INR may be affected.
High-dose extract hepatotoxicity: As noted above, high-dose green tea extract supplements (>800 mg EGCG/day) carry liver injury risk. If using extract supplements, use the lowest effective dose and avoid taking on an empty stomach. Stop use and consult a GP if you develop jaundice, abdominal pain, or unusual fatigue.
Pregnancy: Moderate green tea consumption (one to two cups daily) is generally considered safe in pregnancy. Higher amounts should be avoided due to caffeine content. High-dose green tea extract supplements should be avoided in pregnancy.
Green tea is one of the better-evidenced everyday beverages for cardiovascular and metabolic health. The epidemiological evidence associating high consumption with lower CVD mortality is among the most consistent in nutritional science. The RCT evidence for cholesterol reduction and modest metabolic benefit is real, if modest. As a daily beverage, green tea is a sensible, pleasant, and low-risk healthy habit. High-dose extract supplements carry a safety concern absent from the beverage, and should be used only with awareness of the EFSA hepatotoxicity guidance.
For quality green teas and antioxidant supplements, shop at our partner
Shop at The Honey Pot →